|
⚲
|
| Redox Pharmaceutical Corp | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0000899341 |
| Sale | 2009-10-18 ($2.3 M Offered, $0.1 M Sold) |
| Fund | |
| Phone | 5164842600280 |
| Address | 100 Forest Drive Greenvale, 11548 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Donald Brown |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
BCV Crypto I Private Investors, L.P.
✚
|
0.0 | |
|
DT Asia Investments Ltd
✚
|
0.0 | |
|
DTBS, a series of ALEXTAR VC, LLC
✚
|
0.0 | |
|
DTC Private Equity VIII, L.P.
✚
|
0.0 | |
|
G Squared Opportunities Fund IV LLC Series U-1
✚
|
0.0 | |
|
BCV Crypto I-A Private Investors, L.P.
✚
|
0.0 | |
|
BDC IV Co-Investment Limited Partnership
✚
|
0.0 | |
|
BDPF Retail Holdco REIT LLC
✚
|
0.0 | |
|
BE Fund I, a series of Evolution VC Funds, LP
✚
|
0.0 | |
|
BCV Crypto Fund I-A, L.P.
✚
|
0.0 |